Vertex Pharmaceuticals Inc. buy SVB Leerink LLC
Start price
29.12.25
/
50%
€393.15
Target price
29.12.26
€445.67
Performance (%)
-1.04%
Price
09:04
€389.05
Summary
This prediction is currently active. With a performance of -1.04%, the BUY prediction by SVB_Leerink_LLC is trending in the wrong direction. This prediction currently runs until 29.12.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | -5.467% | -5.467% |
| iShares Core DAX® | -2,12 % | -7,97 % |
| iShares Nasdaq 100 | -1,32 % | -0,07 % |
| iShares Nikkei 225® | -0,32 % | -6,38 % |
| iShares S&P 500 | -1,57 % | -1,97 % |
Comments by SVB_Leerink_LLC for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) had its price target raised by analysts at Leerink Partners from $456.00 to $525.00. They now have an "outperform" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by SVB_Leerink_LLC for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€330.00
25.09.25
25.09.25
€388.33
25.09.26
25.09.26
17.89%
09:04
09:04
